Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group.

Publication Type:

Journal Article


Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2015)


Given concerns that dexrazoxane may reduce treatment efficacy, induce second cancers, and thus compromise overall survival among children, we examined long-term overall and cause-specific mortality and disease relapse rates from three randomized clinical trials.